Alanosine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Alanosine
Skeletal formula of L-alanosine
Ball-and-stick model of the L-alanosine molecule as a zwitterion
Clinical data
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC3H7N3O4
Molar mass149.1 g/mol g·mol−1
3D model (JSmol)
  (verify)

Alanosine (also called SDX-102) is a substance that is being studied for the treatment of pancreatic cancer.[1] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.

References[edit]

  1. ^ Yu J (2001). "Alanosine (UCSD)". Curr Opin Investig Drugs. 2 (11): 1623–30. PMID 11763167.